IP Library Granted Patent US 8,143,366
Granted Patent B2
US 8,143,366 · App. 12/622,645 · Granted Mar 27, 2012

Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same

Assignee: Biocon Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,143,366
App. No.
12/622,645
Granted
Mar 27, 2012
Kind
B2
Abstract

The present invention provides a compound having a formula: where R 1 is selected from the group consisting of alkyl, CH 2 (OC 2 H 4 )OCH 3 , and —(OC 2 H 4 )OCH 3 ; n is 0-4; Olig is an oligomer having a formula: -L-O-PAGR.R 2 ] q where L is a optional linker moiety selected from the group consisting of —CH 2 O—, —CH 2 OX—, —OX—, —C(O)—, —C(O)X, —NH—, —NHC(O)—, —XNHC(O)—, —NHC(O)X—, —C(O)NH—, —C(O)NHX—, and where X is alkyl 1-6 or is not present, Y is N or O or is not present, and R 3 is alkyl 1-6 ; PAG is a linear or branched polyalkylene glycol moiety; R 2 is an alkyl 1-22 capping moiety if X is present or alkyl 2-22 if X is not present; and q is a number from 1 to the maximum number of branches on PAG; and m is 1-5.

Claims (1)

1. An activated compound where an activated moiety is attached to the hydroxyl group and wherein the activated moiety is selected from the group consisting of chloroformate, NHS carbonate, disuccinimidyl carbonate (DSC), phosgene and paranitrophenyl carbonate, wherein the activated compound has a formula selected from the group consisting of:

Continuity (4)
Division 12037445 · Feb 26, 2008
Division 10525290
Provisional Application 60491751 · Aug 1, 2003
Related Publication 20100081782A1 · Apr 1, 2010